Head and Neck Cancer
EDU 10 - (INTERACTIVE) Re-Irradiation in Recurrent or Second Primary Head and Neck Cancer
7:45 AM - 9:00 AM
Location: Lila Cockrell Theatre
Session Type: Educational
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.50 MDCB Credits
This session aims to review the survival, control and toxicity outcomes for patients treated with re-irradiation for recurrent and/or second primary head and neck squamous carcinomas in the IMRT era. Recently published multi-institutional data will be presented which will also shed light on patient selection criteria, prognostic models, choice of technique (IMRT vs. SBRT) as well as future directions in re-irradiation.
- Determine patient selection criteria for re-irradiation based on a validated RPA based prognostic system.
- Describe survival, control and toxicity outcomes for re-irradiation using modern IMRT and SBRT based planning.
- Explain novel approaches in re-irradiation incorporating novel systemic therapeutics as well as brachytherapy.
7:45 AM - 8:05 AM
Patient Selection and treatment outcomes with IMRT based head and neck reirradiation
8:05 AM - 8:25 AM
SBRT based Reirradiation in Head and Neck Cancer: Outcomes and techniques
Speaker: – University of Pittsburgh Cancer Institute
8:25 AM - 8:45 AM
Future Directions in Head and Neck Reirradiation
Speaker: – University Hospitals Case Medical Center
8:45 AM - 9:00 AM